What happens if intradermal injections of rabies vaccine are partially or entirely injected subcutaneously?
Bulletin of the World Health Organization (WHO)
; 68(1): 83-5, 1990. Tab
Article
em En
| PAHO
| ID: pah-7337
Biblioteca responsável:
US1.1
Localização: US1.1, WHO COLL
ABSTRACT
Reported are the results of a study with the Thai Red Cross two-site intradermal purified Vero-cell rabies vaccine (PVRV) schedule that was deliverately injected into subcutaneous tissue. The 44 healthy nonimmune Thai adults who were enrolled in the study were randomly assigned to the following groups and given PVRV as shown group A (two intradermal injections on days 0, 3, and 7); group B (one intradermal and one subcutaneous injection on days 0, 3, and 7); and group C (two subcutaneous injections on days 0, 3, and 7). Neutralizing antirabies antibody titres were determined on day 14 using the rapid fluorescent focus inhibition test. High rabies antibody titres were obtained for all three groups
Buscar no Google
Coleções:
04-international_org
Base de dados:
PAHO
Assunto principal:
Vírus da Raiva
/
Injeções Intradérmicas
/
Vacina Antirrábica
/
Injeções Subcutâneas
/
Anticorpos Antivirais
Tipo de estudo:
Clinical_trials
País/Região como assunto:
Asia
Idioma:
En
Revista:
Bulletin of the World Health Organization (WHO)
Ano de publicação:
1990
Tipo de documento:
Article